Literature DB >> 11325598

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion.

D E Levy1, A García-Sastre.   

Abstract

Response to IFN involves a rapid and direct signal transduction mechanism that quickly reports that presence of extracellular cytokine to the cell nucleus, preserving the specificity inherent in cytokine-receptor interactions to transcriptionally induce expression of a set of genes encoding important antiviral proteins. Establishment of the resulting antiviral state provides a crucial initial line of defense against viral infection. Studies of IFN-deficient cells and animals derived by gene targeting have demonstrated the essential nature of IFN-mediated innate immunity. The long co-evolutionary history of viruses with their hosts has seen the development of a variety of evasive adaptations that allow viruses to circumvent or inactivate host antiviral mechanisms. Further understanding of both host and viral components of this battle may provide important new strategies for vaccine development and creation of novel antiviral compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325598     DOI: 10.1016/s1359-6101(00)00027-7

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  163 in total

1.  Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation.

Authors:  David Khoo; Cesar Perez; Ian Mohr
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice.

Authors:  Nicola R Donelan; Christopher F Basler; Adolfo García-Sastre
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Interferons mediate terminal differentiation of human cortical thymic epithelial cells.

Authors:  Pierre-Olivier Vidalain; David Laine; Yona Zaffran; Olga Azocar; Christine Servet-Delprat; T Fabian Wild; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes.

Authors:  Rongtuan Lin; Ryan S Noyce; Susan E Collins; Roger D Everett; Karen L Mossman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

5.  Virus replication in engineered human cells that do not respond to interferons.

Authors:  D F Young; L Andrejeva; A Livingstone; S Goodbourn; R A Lamb; P L Collins; R M Elliott; R E Randall
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Selective translation of eukaryotic mRNAs: functional molecular analysis of GRSF-1, a positive regulator of influenza virus protein synthesis.

Authors:  John C Kash; Dawn M Cunningham; Maria W Smit; Youngwoo Park; David Fritz; Jeffrey Wilusz; Michael G Katze
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Identification of the nuclear export signal and STAT-binding domains of the Nipah virus V protein reveals mechanisms underlying interferon evasion.

Authors:  Jason J Rodriguez; Cristian D Cruz; Curt M Horvath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively.

Authors:  Megan L Shaw; Adolfo García-Sastre; Peter Palese; Christopher F Basler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  Detection of genome-scale ordered RNA structure (GORS) in genomes of positive-stranded RNA viruses: Implications for virus evolution and host persistence.

Authors:  Peter Simmonds; Andrew Tuplin; David J Evans
Journal:  RNA       Date:  2004-07-23       Impact factor: 4.942

10.  Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.

Authors:  Marc G Wathelet; Melissa Orr; Matthew B Frieman; Ralph S Baric
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.